Journal
DIABETES OBESITY & METABOLISM
Volume 25, Issue 8, Pages 2423-2424Publisher
WILEY
DOI: 10.1111/dom.15114
Keywords
anti-obesity drugs; liraglutide; long-term effects; low and middle-income countries; price transparency; semaglutide